ArticlebioRxiv : the preprint server for biology2024

Haplotype editing with CRISPR/Cas9 as a therapeutic approach for dominant-negative missense mutations in

Poorvi H Dua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.